Cargando…
Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review)
The intricate nature of Alzheimer's disease (AD) pathogenesis poses a persistent obstacle to drug development. In recent times, neuroinflammation has emerged as a crucial pathogenic mechanism of AD, and the targeting of inflammation has become a viable approach for the prevention and management...
Autores principales: | Zheng, Yujia, Zhang, Xiaolu, Zhang, Ruifeng, Wang, Ziyu, Gan, Jiali, Gao, Qing, Yang, Lin, Xu, Pengjuan, Jiang, Xijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558228/ https://www.ncbi.nlm.nih.gov/pubmed/37800614 http://dx.doi.org/10.3892/ijmm.2023.5314 |
Ejemplares similares
-
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
por: Zhang, Xiaolu, et al.
Publicado: (2023) -
Therapeutic Candidates for Alzheimer’s Disease: Saponins
por: Zhang, Ruifeng, et al.
Publicado: (2023) -
Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ
por: Gan, Jiali, et al.
Publicado: (2023) -
Therapeutic Role and Potential Mechanism of Resveratrol in Atherosclerosis: TLR4/NF-κB/HIF-1α
por: Guo, Lin, et al.
Publicado: (2023) -
Application of Metabolite-Responsive Biosensors for Plant Natural Products Biosynthesis
por: Zhang, Jianli, et al.
Publicado: (2023)